US announced 100% tariffs on patented drugs. (Image: AI generated) The pharma sector in India will be in focus after US President Donald Trump has announced up to 100% tariffs on some patented drugs & ...

As 2026 begins, Java Burn reviews are once again climbing search results, not because of hype alone, but because ...

New Delhi: In a significant development in an ongoing pharmaceutical dispute, the Supreme Court of India has declined to interfere with an order of the Allahabad High Court in a case involving Jamp ...

A fully-featured, console-based Cab Booking System built in Java that demonstrates 15 core Object-Oriented Programming concepts through a real-world ride-hailing simulation. The system covers ...

Following the March 20, 2026 patent expiry of semaglutide, India is witnessing a rapid influx of generic GLP-1 receptor agonists. This shift is reshaping market dynamics, with evolving regulatory ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

All the Indian generics are substantially cheaper – the prices vary between Rs 1,300 and Rs 4,500 per month - than the original ones.

Several generic versions of the popular weight loss drug semaglutide are likely to become available Saturday (March 21) onwards, following the expiry of Novo Nordisk’s patent today. Several of India’s ...

India’s obesity drug market is on the cusp of a shake-up, with at least a dozen large drugmakers preparing to launch generic versions of Novo Nordisk’s blockbuster weight-loss drugs as soon as patent ...

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, UK, March 8, 2024. File Image/Reuters India’s drug market is entering a defining moment as the patent on semaglutide ...